Cargando…

Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease

BACKGROUND: Inflammatory bowel disease (IBD), which encompasses both ulcerative colitis (UC) and Crohn’s disease (CD), is a risk factor for venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE). AIM: To investigate the incidence of, and risk factors for,...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujiya, Mikihiro, Kawaguchi, Tsutomu, Arai, Shoko, Isogawa, Naoki, Hiro, Shintaro, Matsumoto, Fumihiro, Yamaguchi, Satoshi, Yoshii, Noritoshi, Nakamura, Mashio, Matsuoka, Katsuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587926/
https://www.ncbi.nlm.nih.gov/pubmed/35150345
http://dx.doi.org/10.1007/s10620-022-07388-w
_version_ 1784814011815034880
author Fujiya, Mikihiro
Kawaguchi, Tsutomu
Arai, Shoko
Isogawa, Naoki
Hiro, Shintaro
Matsumoto, Fumihiro
Yamaguchi, Satoshi
Yoshii, Noritoshi
Nakamura, Mashio
Matsuoka, Katsuyoshi
author_facet Fujiya, Mikihiro
Kawaguchi, Tsutomu
Arai, Shoko
Isogawa, Naoki
Hiro, Shintaro
Matsumoto, Fumihiro
Yamaguchi, Satoshi
Yoshii, Noritoshi
Nakamura, Mashio
Matsuoka, Katsuyoshi
author_sort Fujiya, Mikihiro
collection PubMed
description BACKGROUND: Inflammatory bowel disease (IBD), which encompasses both ulcerative colitis (UC) and Crohn’s disease (CD), is a risk factor for venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE). AIM: To investigate the incidence of, and risk factors for, VTE in patients with IBD in Japan. METHODS: This was a retrospective, non-interventional study in patients with IBD from the Japan Medical Data Center claims database. Incidence rates (IRs; unique patients with events per 100 patient‐years) were calculated for VTE, DVT, and PE among the IBD, UC, and CD cohorts. Odds ratios of potential risk factors were calculated by univariate and multivariate analyses in a nested case–control design. RESULTS: Overall, 16 273 patients with IBD were included: 13 585 with UC and 3443 with CD. VTE events occurred in 1.3%, 1.2%, and 1.9% of patients with IBD, UC, and CD, respectively. In patients with IBD, UC, and CD, IRs of VTE were 0.45, 0.40, and 0.64, respectively, IRs of DVT were 0.42, 0.38, and 0.61, respectively, and IRs of PE were 0.07, 0.07, and 0.11, respectively. In patients with IBD, treatment history (immunomodulators), cardiovascular risk (hypertension, high-density lipoprotein or diabetes mellitus, and history of coronary artery disease or heart failure), malignancy, and undergoing major surgery were identified as potential risk factors for VTE in the multivariate analysis, with similar risk factors reported for patients with UC and CD. CONCLUSIONS: This large study provides insight into the incidence and risk factors for VTE in patients with IBD from Japan. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10620-022-07388-w.
format Online
Article
Text
id pubmed-9587926
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-95879262022-10-24 Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease Fujiya, Mikihiro Kawaguchi, Tsutomu Arai, Shoko Isogawa, Naoki Hiro, Shintaro Matsumoto, Fumihiro Yamaguchi, Satoshi Yoshii, Noritoshi Nakamura, Mashio Matsuoka, Katsuyoshi Dig Dis Sci Original Article BACKGROUND: Inflammatory bowel disease (IBD), which encompasses both ulcerative colitis (UC) and Crohn’s disease (CD), is a risk factor for venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE). AIM: To investigate the incidence of, and risk factors for, VTE in patients with IBD in Japan. METHODS: This was a retrospective, non-interventional study in patients with IBD from the Japan Medical Data Center claims database. Incidence rates (IRs; unique patients with events per 100 patient‐years) were calculated for VTE, DVT, and PE among the IBD, UC, and CD cohorts. Odds ratios of potential risk factors were calculated by univariate and multivariate analyses in a nested case–control design. RESULTS: Overall, 16 273 patients with IBD were included: 13 585 with UC and 3443 with CD. VTE events occurred in 1.3%, 1.2%, and 1.9% of patients with IBD, UC, and CD, respectively. In patients with IBD, UC, and CD, IRs of VTE were 0.45, 0.40, and 0.64, respectively, IRs of DVT were 0.42, 0.38, and 0.61, respectively, and IRs of PE were 0.07, 0.07, and 0.11, respectively. In patients with IBD, treatment history (immunomodulators), cardiovascular risk (hypertension, high-density lipoprotein or diabetes mellitus, and history of coronary artery disease or heart failure), malignancy, and undergoing major surgery were identified as potential risk factors for VTE in the multivariate analysis, with similar risk factors reported for patients with UC and CD. CONCLUSIONS: This large study provides insight into the incidence and risk factors for VTE in patients with IBD from Japan. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10620-022-07388-w. Springer US 2022-02-12 2022 /pmc/articles/PMC9587926/ /pubmed/35150345 http://dx.doi.org/10.1007/s10620-022-07388-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Article
Fujiya, Mikihiro
Kawaguchi, Tsutomu
Arai, Shoko
Isogawa, Naoki
Hiro, Shintaro
Matsumoto, Fumihiro
Yamaguchi, Satoshi
Yoshii, Noritoshi
Nakamura, Mashio
Matsuoka, Katsuyoshi
Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease
title Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease
title_full Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease
title_fullStr Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease
title_full_unstemmed Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease
title_short Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease
title_sort real-world insurance claims analysis of venous thromboembolism in japanese patients with inflammatory bowel disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587926/
https://www.ncbi.nlm.nih.gov/pubmed/35150345
http://dx.doi.org/10.1007/s10620-022-07388-w
work_keys_str_mv AT fujiyamikihiro realworldinsuranceclaimsanalysisofvenousthromboembolisminjapanesepatientswithinflammatoryboweldisease
AT kawaguchitsutomu realworldinsuranceclaimsanalysisofvenousthromboembolisminjapanesepatientswithinflammatoryboweldisease
AT araishoko realworldinsuranceclaimsanalysisofvenousthromboembolisminjapanesepatientswithinflammatoryboweldisease
AT isogawanaoki realworldinsuranceclaimsanalysisofvenousthromboembolisminjapanesepatientswithinflammatoryboweldisease
AT hiroshintaro realworldinsuranceclaimsanalysisofvenousthromboembolisminjapanesepatientswithinflammatoryboweldisease
AT matsumotofumihiro realworldinsuranceclaimsanalysisofvenousthromboembolisminjapanesepatientswithinflammatoryboweldisease
AT yamaguchisatoshi realworldinsuranceclaimsanalysisofvenousthromboembolisminjapanesepatientswithinflammatoryboweldisease
AT yoshiinoritoshi realworldinsuranceclaimsanalysisofvenousthromboembolisminjapanesepatientswithinflammatoryboweldisease
AT nakamuramashio realworldinsuranceclaimsanalysisofvenousthromboembolisminjapanesepatientswithinflammatoryboweldisease
AT matsuokakatsuyoshi realworldinsuranceclaimsanalysisofvenousthromboembolisminjapanesepatientswithinflammatoryboweldisease